Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: Chronic myelogenous leukemia presenting in lymphoid blast phase vs Ph+ acute lymphoblastic leukemia

Leukemia

Volumn 10, Issue 5, 1996, Pages 795-802

  Anastasi, J ^a,b   Feng, J ^a   Dickstein, J I ^a   Le Beau, M M ^a   Rubin, C M ^a   Larson, R A ^a   Rowley, J D ^a   Vardiman, J W ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

BCR ABL; CML; Lineage; Lymphoblastic leukemia

Indexed keywords

BCR ABL PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLAST CELL CRISIS; BONE MARROW; CHILD; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; MALE; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; STEM CELL;

EID: 0029892567     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Cline MJ. The molecular basis of leukemia. New Engl J Med 1994; 330: 328-336.
2. Westbrook CA, Hooberman AL, Spino C, Dodge RK, Larson RA, Davey F, Wurster-Hill DH, Sobol RE, Schiffer C, Bloomfield CD. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B study (8762). Blood 1992; 80: 2983-2990.
3. Ribeiro RC, Abromowitch M, Raimondi SC, Murphy SB, Behm F, Williams DL. Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia. Blood 1987; 70: 948-953.
4. Gale RP, Butturini A. Ph-chromosome positive acute leukemias and acute phase CML: one or two diseases? Two. Leukemia Res 1990; 14: 295-297.
5. Berger R. Differences between blastic chronic myeloid leukemia and Ph-positive acute leukemia, Leuk Lymphoma 1993; 11 (suppl.1): 235-237.
6. Beard MEJ, Durrant I, Catovsky D, Wiltshaw E, Amess JL, Brearley RL, Kirk B, Wrigley PFM, Janossy C, Greaves MF, Galton DAG. Blast crisis of chronic myeloid leukemia (CML). I. Presentation simulating acute lymphoid leukemia (ALL). Br J Hameatol 1976; 34: 167-178.
7. Rowley JD. Ph1-positive leukemia, including chronic myelogenous leukemia. Clin Haematol 1980; 9: 55-86.
8. BCR-ABL chronic myeloid leukemia: the missing link with chronic myelomonocytic leukemia? Leukemia 1994; 8: 208-211.
9. Dow LW, Tachibana N, Raimondi SC, Lauer SJ, Witte ON, Clark SS. Comparative biochemical and cytogenetic studies of childhood acute lymphoblastic leukemia with the Philadelphia chromosome and other 22q11 variants. Blood 1989; 73: 1291-1297.
10. Kantarjian HM, Talpaz M, Dhingra K, Estey E, Keating MJ, Ku S, Truillo J, Huh Y, Stass S, Kurzrock R, Significance of p210 versus pi 90 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood 1991; 78: 2411-2418.
11. Abe R, Ishibashi T, Kimura H, Uchida T, Kariyone S. The significance of cytogenetic findings of erythroid colonies derived from a Ph+ ALL patient: fundamental differences between Ph+ ALL and blastic phase of CML. Cencer Genet Cytogenet 1985; 18: 49-54.
12. Secker-Walker LM, Cooke HMG, Browett PJ, Shippey CA, Norton JD, Coustan-Smith E, Hoffbrand AV. Variable Philadelphia breakpoints and potential lineage restriction of bcr rearrangement in acute lymphoblastic leukemia. Blood 1988; 72: 784-791.
13. Kalousek DK, Dube ID, Eaves CJ, Eaves AC. Cytogenetic studies of haemopoietic colonies from patients with an initial diagnosis of acute lymphoblastic leukaemia. Br J Haematol 1988; 70: 5-11.
14. Suryanarayan K, Hunger SP, Kohler S, Carroll AJ, Crist W, Link MP, Cleary ML. Consistent involvement of the BCR gene by 9:22 breakpoints in pediatric acute leukemias. Blood 1991; 77: 324-330.
15. Tachibana N, Raimondi SC, Lauer SJ, Sartain P, Dow LW. Evidence for a multipotential stem cell disease in some childhood Philadelphia chromosome-positive acute lymphoblastic leukemias. Blood 1987; 70: 1458-1461.
16. Kitano K, Sato Y, Suda T, Miura Y. Difference of cell lineage expression of haematopoietic progenitor cells in Philadelphia-positive acute lymphoblastic leukaemia and chronic myelogenous leukaemia. Br J Haematol 1988; 70: 21-26.
17. Craig JM, Hawkins JM, Yamada T, Ganeshaguru K, Mehta AB, Secker-Walker LM. First intron and M-bcr breakpoints are restricted to lymphoid lineage in Philadelphia positive acute lymphoblastic leukemia. Leukemia 1990; 4: 678-681.
18. Secker-Walker LM, Graig JM. Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: a review. Leukemia 1993; 7: 147-151.
19. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D. Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science 1990; 250: 559-562.
20. Arnoldus EPJ, Weigant J, Noordermeer IA, Wessels JW, Beverstock GC, Grosveld GC, van der Ploeg M, Raap AK. Detection of the Philadelphia chromosome in interphase nuclei. Cytogenet Cell Genet 1990; 54: 108-111.
21. Dewald GW, Schad CR, Christensen ER, Tiede AL, Zinsmeister AR, Spurbeck JL, Thibodeau SN, Jalal SM. The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genet Cytogenet 1993; 71: 7-14.
22. Torlakovic E, Litz CE, McClure JS, Brunning RD. Direct detection of the Philadelphia chromosome in CD20-positive lymphocytes in chronic myeloid leukemia by tri-color immunophenotyping/FISH. Leukemia 1994; 8: 1940-1943.
23. Tefferi A, Schad CR, Pruthi RK, Ahmann GJ, Spurbeck JL, Dewald GW. Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia. Cancer Genet Cytogenet 1995; 83: 61-64.
24. Anastasi J, Vardiman JW, Rudinsky R, Patel M, Nachman JB, Rubin CM, Le Beau MM. Direct correlation of cytogenetic findings with cell morphology by in situ hybridization: an analysis of suspicious cells from bone marrow specimens of two patients completing therapy for lymphoblastic: leukemia. Blood 1991; 77: 2456-2462.
25. Kibbelaar RE, van Kamp H, Dreef EJ, de Groot-Swings G, Kluin-Nelemans JC, Beverstock GC, Fibbe WE, Kluin PM. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes. Blood 1992; 79: 1823-1828.
26. Gerritsen WR, Donohue J, Bauman J, Jhanwar SC, Kernan NA, Castro-Malaspina H, O'Reilly RJ, Bourhis JH. Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. Blood 1992; 80: 217-224.
27. Weber-Matthiesen K, Winkemann M, Muller-Hermelink A, Schlegelberger B, Grote W. Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. J Histochem Cytochem 1992; 40: 171-175.
28. ISCN (1991). Mitelman F. Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Karger: Basel 1991.
29. Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Vardiman JW. Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factors, and clone expansion. Blood 1993; 81: 1580-1585.
30. Bentz M, Cabot C, Moos M, Speicher MR, Ganser A, Lichter P Dohner H. Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 1994; 83: 1922-1928.
31. Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Vardiman JW. The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia. Leukemia 1995; 9: 628-633.
32. Nguyen PL, Arthur DC, Litz CE, Brunning RD. Fluorescence in situ hybridization (FISH) detection of trisomy 8 in myeloid cells in chronic myeloid leukemia (CML): a study of archival blood and bone marrow smears. Leukemia 1994; 8: 1654-1662.
33. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
34. Derderian PM, Kantarjian HM, Talpaz M, O'Brien S, Cork A, Estey E, Pierce S. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response and prognosis. Am J Med 1993; 94: 69-74.
35. Roman J, Andres P, Jimenez MA, Torres A. Lymphoid blast crisis at the onset of chronic myelogenous leukemia: molecular evidence. Br J Haematol 1994; 87: 624-626.
36. Fujie H, Tsuchiya S, Morita S, Itano M, Yambe T, Ohasi Y, Minegtshi N, Minegishi M, Satou T, Konno T. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis. Leukemia 1994; 8: 1592-1595.
37. Goldman JM, Szydlo R, Horowitz MM, Gale RP, Ash RC, Atkinson K, Dicke KA, Gluckman E, Herzig RH, Marmont A, Masaoka T, McGlave PB, Messner H, O'Reilly RJ, Reiffers J, Rimm AA, Speck B, Veum-Stone JA, Wingard JR, Zwaan FE, Bortin MM. Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood 1993; 82: 2235-2238.
38. Clift RA, Applebaum FR, Thomas ED. Treatment of chronic myeloid leukemia by marrow transplantation. Blood 1993; 82: 1954-1956.
39. Mehrotra B, George TI, Kavanau K, Avet-Loiseau H, Moore D, Willman CL, Slovak ML, Atwater S, Head DR, Pallavicini MG. Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia. Blood 1995; 86: 1139-1147.
40. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818-821.
41. Maser RL, Clavet IP. Analysis of differential gene expression in the kidney by differential cDNA screening, subtractive cloning, and mRNA differential display. Semin Nephrol 1995; 15: 29-42.